WHITE PAPERS & CASE STUDIES

PRODUCTS & SERVICES

Our solutions have been specified in the testing process for the top two GLP-1 manufacturers

Bioanalytical organizations are responsible for generating accurate, reproducible data that supports development decisions, regulatory submissions and ultimately faster drug approvals. As sample volumes grow and studies become more complex, maintaining quality, compliance and efficiency can become increasingly difficult.

IDBS Polar Request brings lab work request management directly into the Polar platform—alongside experiment execution, structured workflows and compliance. It connects the demand for scientific work to the people, inventory and capacity needed to deliver it.

Synthetic oligonucleotide therapeutics, such as antisense oligonucleotides (ASOs) and small interfering RNAs (si-RNAs), require thorough analysis to establish purity and quality.

Analyzing GLP-1 receptor agonist (RA) drugs has become increasingly complex. Peptide structures, closely-related impurities, and rising demands for sensitivity, speed, and compliance are putting pressure on laboratories.

Designed for highly potent compounds, the platform supports ADC development from early-stage research through GMP manufacturing and commercial scale-up.

Built on a foundation of quality, compliance, and operational excellence, our systems support your program from development through commercial supply across global regulatory markets.

The CC-IS is a Cell Culture Isolator cGMP Class A/ISO 5 system specifically designed to provide the users with a cell culture environment which is safer than environments on traditional biosafety cabinets, clean booths or standard cleanrooms, by eliminating any risk from human contamination of cell cultures.